301.694.2999

DONATE NOW

Press Releases

 

PRONAV Clinical Embarks on U.S. Expansion with Soft Landing at FITCI

By

April Bartel

|

FITCI (Frederick Innovative Technology Center, Inc.) proudly welcomes PRONAV Clinical, an internationally acclaimed early-phase clinical trial supply partner headquartered in Ireland, to its vibrant entrepreneurial ecosystem in partnership with Maryland’s … Read more

Cornerstone Genomics Launches CodeXome: A Revolutionary Tool for Genetic Research & Rare Disease Cures

By

|

Cornerstone Genomics, a pioneer in advanced genomic research software, proudly announces the launch of CodeXome, a groundbreaking all-in-one platform designed to accelerate the discovery of genetic targets by providing researchers … Read more

Mesa Science Associates Joins Forces with MedSurgPI , LLC

By

|

FITCI Capstone member expands convenience and capability for startup biotech firms. FREDERICK, Md., Aug. 20, 2024 — Mesa Science Associates, Inc. (MSA) and MedSurgPI, LLC announced a partnership between their two companies, which will expand … Read more

Phycin wins $200K TEDCO Investment

By

|

Press release by TEDCO Maryland-based company seeks to revolutionize green algae growth factors TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Pre-Seed Builder Fund investment in Phycin, … Read more

Patrick Wheeler Named Chairman of the Board for FITCI

By

FITCI Board

|

“Patrick’s leadership and vision will be instrumental to FITCI as we expand into the next generation of FITCI and continue to drive innovation and support the growth of technology startups … Read more

Theradaptive, FITCI grad, Secures Landmark Funding from Maryland Stem Cell Research Fund (MSCRF) to Support Human Clinical Trials

By

Harry Warne

|

FREDERICK, Md., May 22, 2024 /PRNewswire/ — Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced today it has been awarded funding from the Maryland Stem Cell Research Fund (MSCRF) to … Read more

OspreyBio Completes Development of the Bird of Prey platform, Greatly Simplifying Building of Complex Multigenic Vectors

By

Lilith Saylor

|

Osprey BioScience, LLC, a gene and cell therapy biotools company and subsidiary of privately-held BioSolution Designs (www.biodzn.com) plans to unveil Bird of Prey at the 27th annual meeting of the … Read more

BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies

By

Lilith Saylor

|

BioSolution Designs is pleased to announce the formation of its first drug development subsidiary, BeatBio, created to develop complex multigenic therapeutics for cardiovascular diseases. The company, headquartered in Cincinnati, is … Read more

BioSolution Designs and RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development

Community Collaboration

By

Lilith Saylor

|

BioSolution Designs (BSD), a biotechnology invention studio developing proprietary platforms for multigenic gene and cell therapies, today announced its ongoing strategic collaboration with RoosterBio, a leading provider of human mesenchymal … Read more

BioSolution Designs Announces New Management Team Member

By

Lilith Saylor

|

BioSolution Designs is pleased to announce that Shruti Abbato has joined the company as Chief Development Officer. Shruti brings two decades of biopharmaceutical corporate development expertise across biologics and gene … Read more

12311 Next